March 15, 2016 / 2:24 PM / in a year

BUZZ-Valeant's dim forecast infects specialty pharma stocks

** Shares of specialty pharmaceutical cos get clipped after beleaguered Valeant Pharmaceuticals slashes its 2016 forecast

** U.S.-listed Valeant shares now down 40 pct to more than 4-year low

** Mallinckrodt and Endo International fall in sympathy and among biggest S&P 500 index losers, both down nearly 7 pct; Horizon Pharma PLC drops 9 pct

** Trader says Valeant's woes should be less of a fundamental read across to Mylan NV and Teva Pharmaceutical Industries ; MYL down 3 pct, U.S.-listed TEVA shares off 4 pct

** Specialty pharma stocks have been hurt by questions facing Valeant over pricing and other business practices

RM: lance.tupper.tr.com@reuters.net

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below